Surgical Insights Are Essential to Integration of Immune Therapy in Resectable NSCLC

Código QR

Surgical Insights Are Essential to Integration of Immune Therapy in Resectable NSCLC

Guardado en:

Detalles Bibliográficos
Autor principal:	Jessica S. Donington, MD
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/21750f76cf8345c28ffbd2a0f444a723
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

AXL receptor tyrosine kinase as a therapeutic target in NSCLC
por: Okimoto RA, et al.
Publicado: (2015)

MET overexpression and gene amplification in NSCLC: a clinical perspective
por: Landi L, et al.
Publicado: (2013)

TACE Combined with HIFU Versus Surgical Resection for Single Hepatocellular Carcinoma with Child-Pugh B Cirrhosis in Overall Survival and Progression-Free Survival: A Retrospective Study
por: Qiwei Zhang MM, et al.
Publicado: (2021)

Practical management of NSCLC patients with long-term bevacizumab treatment: a report of four cases
por: Herder GJM, et al.
Publicado: (2013)

CD8+ TILs in NSCLC differentiate into TEMRA via a bifurcated trajectory: deciphering immunogenicity of tumor antigens
por: Sung-Woo Lee, et al.
Publicado: (2021)

Combined FGFR and Akt pathway inhibition abrogates growth of FGFR1 overexpressing EGFR-TKI-resistant NSCLC cells
por: Mikkel G. Terp, et al.
Publicado: (2021)

A multi-omics study links TNS3 and SEPT7 to long-term former smoking NSCLC survival
por: Sipeng Shen, et al.
Publicado: (2021)

Recognizing Prognostic and Predictive Biomarkers in the Treatment of Non-Small Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors (ICIs)
por: Giustini N, et al.
Publicado: (2021)

Treatment patterns, testing practices, and outcomes in the pre-FLAURA era for patients with EGFR mutation-positive advanced NSCLC: a retrospective chart review (REFLECT)
por: Alfredo Addeo, et al.
Publicado: (2021)

Correction: Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies
Publicado: (2021)

Immunotherapy for Stage III NSCLC: Durvalumab and Beyond
por: Fitzpatrick O, et al.
Publicado: (2021)

Evaluating Incidence, Location, and Predictors of Positive Surgical Margin Among Chinese Men Undergoing Robot-Assisted Radical Prostatectomy
por: Wugong Qu MSc, et al.
Publicado: (2021)

Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes
por: Kirby P. Gardner, et al.
Publicado: (2021)

Treatments for the early stage Hepatocellular Carcinoma: Laparoscopic Liver Resection or Percutaneous Radiofrequency, How to make the decision?
por: Jinli Zheng, et al.
Publicado: (2021)

The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer
por: Barbara Melosky, et al.
Publicado: (2021)

Molecular targeted therapy for advanced or metastatic soft tissue sarcoma
por: Jin Yuan MD, et al.
Publicado: (2021)

Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer
por: Michael Dougan, et al.
Publicado: (2021)

MET Amplification and Efficacy of Nivolumab in Patients With NSCLC
por: Katsuhiro Yoshimura, MD, PhD, et al.
Publicado: (2021)

Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity
por: Alberto Mantovani, et al.
Publicado: (2021)

Correction: Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer
Publicado: (2021)

In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis
por: In-San Kim, et al.
Publicado: (2021)

Correction: In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis
Publicado: (2021)

Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model
por: Chiao-Fang Teng, et al.
Publicado: (2020)

Targeting AXL in NSCLC
por: Zaman A, et al.
Publicado: (2021)

MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer
por: Kwok-Kin Wong, et al.
Publicado: (2021)

Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence
por: Omid Hamid, et al.
Publicado: (2021)

Correction: MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer
Publicado: (2021)

Dosimetric Comparison of Helical Tomotherapy and Intensity-Modulated Proton Therapy in Hippocampus- and Scalp-Sparing Whole Brain Radiotherapy
por: Taiki Takaoka MD, PhD, et al.
Publicado: (2021)

Use of Intraoperative Frozen Section in the Surgical Management of Patients with Nonmelanoma Skin Cancer
por: LiAnn Loh, et al.
Publicado: (2021)

Correction notice to “Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model”
por: Chiao-Fang Teng, et al.
Publicado: (2021)

Outcomes of neoadjuvant chemotherapy in resectable, borderline resectable and locally advanced pancreatic cancer
por: Kamil D. Dalgatov, et al.
Publicado: (2021)

MPL S505C enhances driver mutations at W515 in essential thrombocythemia
por: Leila N. Varghese, et al.
Publicado: (2021)

Effect of Fuzheng Qingdu Therapy for Metastatic Gastric Cancer is Associated With Improved Survival: A Multicenter Propensity-Matched Study
por: Chao Hou MD, et al.
Publicado: (2021)

Endothelial cell malignancies: new insights from the laboratory and clinic
por: Michael J. Wagner, et al.
Publicado: (2017)

Clinical Research Progress of Radiotherapy Combined with Immune Checkpoint Inhibitors on NSCLC
por: ZHU Kuikui, et al.
Publicado: (2021)

Psychiatric morbidity among Egyptian breast cancer patients and their partners and its impact on surgical decision-making
por: Abdel Wahab KM, et al.
Publicado: (2012)

Lgr5 is a marker for fetal mammary stem cells, but is not essential for stem cell activity or tumorigenesis
por: Christy L. Trejo, et al.
Publicado: (2017)

Correlation Between Average Segment Width and Gamma Passing Rate as a Function of MLC Position Error in Volumetric Modulated Arc Therapy
por: Young Min Moon PhD, et al.
Publicado: (2021)

Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy
por: Andrew Haydon, et al.
Publicado: (2021)

Real-world data analyses unveiled the immune-related adverse effects of immune checkpoint inhibitors across cancer types
por: Feicheng Wang, et al.
Publicado: (2021)